EMA Authorised: Epivir (lamivudine) — ViiV Healthcare BV

View source ↗

Summary

Epivir (lamivudine) has been authorised in the European Union for HIV infections.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Drugs mentioned

• Epivir (Lamivudine)

Snippet

Status: Authorised. Therapeutic area: HIV Infections. MAH: ViiV Healthcare BV. Decision date: 11/08/2022